Inozyme Pharma Inc (INZY)
4.605
-0.12
(-2.64%)
USD |
NASDAQ |
May 17, 16:00
4.605
0.00 (0.00%)
After-Hours: 17:18
Inozyme Pharma Total Assets (Quarterly): 176.94M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 176.94M |
| December 31, 2023 | 200.85M |
| September 30, 2023 | 205.70M |
| June 30, 2023 | 150.93M |
| March 31, 2023 | 141.80M |
| December 31, 2022 | 139.20M |
| September 30, 2022 | 154.02M |
| June 30, 2022 | 161.99M |
| March 31, 2022 | 108.93M |
| Date | Value |
|---|---|
| December 31, 2021 | 123.54M |
| September 30, 2021 | 137.75M |
| June 30, 2021 | 148.26M |
| March 31, 2021 | 158.92M |
| December 31, 2020 | 169.36M |
| September 30, 2020 | 178.99M |
| June 30, 2020 | 68.51M |
| March 31, 2020 | 75.74M |
| December 31, 2019 | 47.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
47.94M
Minimum
Dec 2019
205.70M
Maximum
Sep 2023
141.63M
Average
149.59M
Median
Total Assets (Quarterly) Benchmarks
| Xeris Biopharma Holdings Inc | 336.62M |
| Kodiak Sciences Inc | 479.37M |
| Phathom Pharmaceuticals Inc | 356.50M |
| Athira Pharma Inc | 160.24M |
| Disc Medicine Inc | 354.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.11M |
| Shareholders Equity (Quarterly) | 118.84M |